A detailed history of Vital Stone Financial, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Vital Stone Financial, LLC holds 162 shares of ABT stock, worth $18,383. This represents 0.01% of its overall portfolio holdings.

Number of Shares
162
Previous 161 0.62%
Holding current value
$18,383
Previous $16,000 12.5%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$100.07 - $118.13 $100 - $118
1 Added 0.62%
162 $18,000
Q2 2024

Aug 07, 2024

SELL
$100.73 - $112.44 $503 - $562
-5 Reduced 3.01%
161 $16,000
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $721 - $883
-8 Reduced 4.6%
166 $18,000
Q3 2023

Nov 15, 2023

SELL
$95.53 - $114.62 $764 - $916
-8 Reduced 4.4%
174 $16,000
Q2 2023

Aug 21, 2023

BUY
$100.78 - $112.29 $18,341 - $20,436
182 New
182 $18,000
Q4 2022

Jan 30, 2023

BUY
$95.06 - $111.52 $15,209 - $17,843
160 New
160 $18 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Vital Stone Financial, LLC Portfolio

Follow Vital Stone Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vital Stone Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vital Stone Financial, LLC with notifications on news.